載入...
4CPS-109 Experience of regorafenib use in metastatic colorectal cancer
BACKGROUND: Regorafenib has been approved for the treatment of patients with previously treated metastatic colorectal cancer (mCRC), and may be considered as a treatment for selected patients. PURPOSE: To evaluate the efficacy and safety of regorafenib treatment in patients with mCRC. MATERIAL AND M...
Na minha lista:
| 發表在: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Group
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535196/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.200 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|